COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
DBV Technologies screens first participant in THRIVE Phase 2 study of VIASKIN Peanut Patch for infants with peanut allergy. Study aims to achieve ad lib consumption of dietary peanut in infants 6-12 months -
COMMUNIQUÉ DE PRESSE
DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés de 6 à 12 mois allergiques à l’arachide
DBV Technologies a annoncé le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons allergiques à l’arachide -
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Onco-Innovations successfully scales kilogram manufacturing for ONC010 B4 precursor component, advancing nanoparticle-formulated PNKP Inhibitor Technology. Engages InvestorBrandNetwork (IBN) for market services -
-
COMMUNIQUÉ DE PRESSE
Hycroft Delivers $10 Billion NPV from Technical Report at Spot Prices While Advancing High-Grade Brimstone and Vortex Silver Discoveries
Hycroft Mining Holding reports $10 billion NPV from Technical Report on Hycroft Mine economics and mine plan, leveraging rising gold and silver prices. Significant growth potential with high-grade discoveries Brimstone and Vortex -
-
-
![Logo de [UNKNOWN]](https://logos.symex.be/img/.jpg)
